Analysis of right-to-health litigation involving high-cost medicines in Brazil: a scoping review protocol
DOI:
https://doi.org/10.33448/rsd-v11i15.37584Keywords:
Health's Judicialization; Health litigation for access to medicines; Scoping review; Medicines.Abstract
Many studies investigating right to health litigation involving medicines mention “high-cost medicines”. However, detailed data on the characteristics of legal claims for these drugs and their share in terms of volume and spending in right to health litigation involving medicines is scarce. This paper presents a protocol for a scoping review that seeks to determine the profile of legal claims for high-cost medicines in Brazil and calculate the volume of purchases and amount spent on these drugs as a share of overall volume and spending related to right to health litigation involving medicines. Structured following the PRISMA-P checklist, this protocol describes the stages of the methodological framework for conducting the review. Guided by the PCC mnemonic (Population, Concept and Context), we searched for articles and other academic research reports published from 2000 to the present date using the MEDLINE, Embase, LILACS, Scopus, and Web of Science databases and the Brazilian Digital Library of Theses and Dissertations, respectively. Study selection will be performed in two stages (reading of titles and abstracts and assessment of the full-text version of the articles) by two independent reviewers. Any disagreements will be resolved by a third reviewer. We will perform a qualitative and quantitative analysis of the results, which will be presented in a descriptive format using figures, tables, and diagrams. The final review report will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Scoping Reviews (PRISMA-ScR) checklist. This protocol is registered with the Open Science Framework (DOI: 10.17605/OSF.IO/8PXUB).
References
Andia, T.S., & Lamprea, E. (2019). Is the judicialization of health care bad for equity? A scoping review. International Journal for Equity Health, 18(61), 1-12. https://doi.org/10.1186/s12939-019-0961-y
Arksey, H., & O’Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19–32. https://doi.org/10.1080/1364557032000119616
Aromataris, E., & Munn, Z. (Editors). (2020) JBI Manual for Evidence Synthesis. Chapter 11: Scoping Reviews. Disponível em: https://doi.org/10.46658/JBIMES-20-01
Bardin L. (1977) Análise de conteúdo. Lisboa: Edições 70 Ltda.
Boing, A., Bloemer, N.S., Roesler, C., & Fernandes, S. (2013). A judicialização do acesso aos medicamentos em Santa Catarina: um desafio para gestão do sistema de saúde. Revista de Direito Sanitário, 4(1), 82-97. https://doi.org/10.11606/issn.2316-9044.v14i1p82-97
Borges, D.D.C.L. (2018). Individual Health Care Litigation in Brazil through a Different Lens: Strengthening Health Technology Assessment and New Models of Health Care Governance. Health and Human Rights Journal, 20(1) 147-162. https://www.hhrjournal.org/2018/06/individual-health-care-litigation-in-brazil-through-a-different-lens-strengthening-health-technology-assessment-and-new-models-of-health-care-governance/
Catanheide, I. D., Lisboa, E. S., & Souza, L. E. P. F. (2016). Características da judicialização do acesso a medicamentos no Brasil: uma revisão sistemática. Physis Revista de Saúde Coletiva, 26(4), 1335-1356. https://doi.org/10.1590/S0103-73312016000400014.
Chagas, C. P., & Santos, F. P. (2018). Efeitos do gasto com a judicialização da saúde no orçamento da Secretaria Estadual de Saúde do Distrito Federal entre 2013 e 2017. Cadernos Ibero-Americanos De Direito Sanitário, 7(2), 147–172. https://doi.org/10.17566/ciads.v7i2.496.
Chieffi, A.L., & Barradas, R.B. (2009). Judicialização da política pública de assistência farmacêutica e eqüidade. Cadernos de Saúde Pública, 25(8), 1839-1849. https://doi.org/10.1590/S0102-311X2009000800020
Chieffi, A. L., Barradas, R. C. B., & Golbaum, M. (2017). Legal access to medications: a threat to Brazil’s public health system? BMC Health Services Research, 17(499), 1-12. https://doi.org/10.1186/s12913-017-2430-x
Constituição da República Federativa do Brasil de 1988. (1988). Brasília. http://www.planalto.gov.br/ccivil_03/constituicao/constituicao.htm.
Dana, K. N., Hertig, J. B., & Weber. R.J. (2017) Drug Pricing Transparency: The New Retail Revolution. Hospital Pharmacy, 52(2), 155-159. https://doi.org/10.1310/hpj5202-155
Daudt, H. M., Van Mossel, C. & Scott, S. J. (2013). Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Medical Research Methodology, 13(48), 1-9. https://doi.org/10.1186/1471-2288-13-48.
Ferraz, O. L. (2009). The right to health in the courts of Brazil: worsening health inequities? Health Hum Rights, 11(2), 33-45. https://www.hhrjournal.org/2013/08/the-right-to-health-in-the-courts-of-brazil-worsening-health-inequities/.
Freitas, B. C., Fonseca, E. P., & Queluz, D. P. (2020) A Judicialização da saúde nos sistemas público e privado de saúde: uma revisão sistemática. Interface, 24 (e190345), 1-17. https://doi.org/10.1590/Interface.190345.
Kavanagh, M. M. (2016). The Right to Health: Institutional Effects of Constitutional Provisions on Health Outcomes. Studies in Comparative International Development, 51, 328–364. https://doi.org/10.1007/s12116-015-9189-z.
Khalil, H., Peters, M., Godfrey, C. M., McInerney, P., Soares, C. B., & Parker, D. (2016). An evidence-based approach to scoping reviews. Worldviews on Evidence-Based Nursing, 13(2), 118–123. https://doi.org/10.1111/wvn.12144.
Libanore, A. C. (2020) Medicamentos de alto custo segundo a perspectiva do SUS [Dissertação de mestrado, Universidade de São Paulo]. Repositório institucional da Universidade de São Paulo. https://www.teses.usp.br/teses/disponiveis/9/9139/tde-11102021-144856/publico/Alexandre_de_Castro_Libanore_ME_Original.pdf
Lopes, L. M. N., Coelho, T. L., Diniz, S. D. & Andrade, E. I. G. (2019). Integralidade e universalidade da assistência farmacêutica em tempos de judicialização da saúde. Saúde e Sociedade, 28(2), 124-131. https://doi.org/10.1590/S0104-12902019180642.
Lopes, S. A. G. P., Dolabela-Barneche, L., Dolabela, M. F., & Ribeiro, K. D. (2021) Judicialization of medicines and their political-administrative legal and economic aspects: an integrative review. Research, Society and Development, 10(13), e107101320660, 2021. https://doi.org/10.33448/rsd-v10i13.20660.
Munn, Z., Peters, M. D. J., Stern, C., Tufanaru, C., McArthur, A., & Aromataris, E. (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology, 18(1), 143. https://doi.org/10.1186/s12874-018-0611-x.
Oliveira, D. C. (2008) Análise de Conteúdo Temático Categorial: Uma proposta de sistematização. Rev. Enferm. UERJ, Rio de Janeiro, 16(4), 569-76. http://files.bvs.br/upload/S/0104-3552/2008/v16n4/a569-576.pdf
OPAS. Organização Pan-Americana da Saúde. (2009). O acesso aos medicamentos de alto custo nas Américas: contexto, desafios e perspectivas. Brasília: Organização Pan-Americana da Saúde / Ministério da Saúde. https://bvsms.saude.gov.br/bvs/publicacoes/acesso_medicamentos_alto_custo_americas.pdf.
Page, M. J., McKenzie, J .E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. K., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalul, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., & McGuinness, L. A. (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372 (71), 1-9. https://doi.org/10.1136/bmj.n71.
Pepe, V. L. E., Figueiredo, T. A., Simas, L., Osorio-de-Castro, C .G. S., & Ventura, M. (2010). A judicialização da saúde e os novos desafios da gestão da assistência farmacêutica. Revista Ciência & Saúde Coletiva, 15 (5), 2405-2414. https://www.scielo.br/j/csc/a/L4m7NMGV397wCRGnZthwJrD/?format=pdf&lang=pt.
Pepe, V. L. E., Ventura, M., Osório-de-Castro, C. G. S. (Organizadoras) (2011). Manual de Indicadores de Avaliação e Monitoramento das Demandas Judiciais de Medicamentos. Rio de Janeiro: ENSP/Fiocruz. http://www4.ensp.fiocruz.br/biblioteca/dados/txt_975659982.pdf
Peters, M. D .J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., Mclnerney, P., Godfrey, C. M., & Khalil, H. (2020) Updated methodological guidance for the conduct of scoping reviews. JBI evidence Synthesis, 18(10), 2119-2126. https://doi.org/10.11124/JBIES-20-00167
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. British Medical Journal, 349 (g7647), 1-25. https://doi.org/10.1136/bmj.g7647.
Silva, E. M., Almeida, K. C., & Pessôa, G. S.C. (2017). Análise do gasto com judicialização de medicamentos no Distrito Federal, Brasil. Cadernos Ibero-Americanos de Direito Sanitário, 6(1), 112-126. http://dx.doi.org/10.17566/ciads.v6i1.358.
Silveira, L., Barbosa, A. D., Ferreira, M. K., & Caregnato, S. E. (2020). Citação de dados científicos: scoping review. Encontros Bibli: Revista Eletrônica de Biblioteconomia e Ciência da Informação, 25, 1-31. https://doi.org/10.5007/1518-2924.2020.e72153.
Souza, M. V., Krug, B. C., Picon, P. D., & Schwartz, I. V. D. (2010) Medicamentos de alto custo para doenças raras no Brasil: o exemplo das doenças lisossômicas. Ciência & Saúde Coletiva, 15 (3), 3443-3454. https://doi.org/10.1590/S1413-81232010000900019.
TCU. Tribunal de Contas da União. Auditoria operacional sobre judicialização da saúde: ficha síntese. Brasília: TCU, 2017. https://portal.tcu.gov.br/biblioteca-digital/auditoria-operacional-sobre-judicializacao-da-saude.htm. Acessed 22.08.2022.
Tricco, A. C., Lillie, E., Zarin, W., O'Brien K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E .A., Chand, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garrity, C., Lewin, S., ... & Straus, S. E. (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine, 169(7), 467-473. https://doi.org/10.7326/M18-0850.
Yamauti, S. M., Barreto, J. O .M., Barberato-Filho, S., & Lopes, L. C. (2020) Strategies Implemented by Public Institutions to Approach the Judicialization of Health Care in Brazil: A Systematic Scoping Review. Frontiers in Pharmacology, 11(1128), 1-18. https://doi.org/10.3389/fphar.2020.01128.
Zago, B., Swiech, L. M., Bonamigo, E., & Schlemper Junior, B.R. (2016). Bioethical Aspects of Health Judicialization for drugs in 13 Municipalities in the Midwest of Santa Catarina, Brazil. Acta bioethica, 22(2), 293-302. http://dx.doi.org/10.4067/S1726-569X2016000200016.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rosângela Caetano; Ione Ayala Gualandi de Oliveira; Lívia Teixeira de Mattos; Patrícia Krauze; Claudia Garcia Serpa Osorio-de-Castro
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
